Recent progress in bioconjugation strategies for liposome-mediated drug delivery
In nanoparticle (NP)-mediated drug delivery, liposomes are the most widely used drug
carrier, and the only NP system currently approved by the FDA for clinical use, owing to their …
carrier, and the only NP system currently approved by the FDA for clinical use, owing to their …
[HTML][HTML] An overview of nanoparticles in drug delivery: properties and applications
Today, in diverse medical and clinical fields, including cancer treatment, nanoscience has
evolved and evolved. Cancer and its forms, on the other hand, have been rumored and …
evolved and evolved. Cancer and its forms, on the other hand, have been rumored and …
Small interfering RNAs (siRNAs) in cancer therapy: a nano-based approach
G Mahmoodi Chalbatani, H Dana… - International journal …, 2019 - Taylor & Francis
Cancer is one of the most complex diseases that has resulted in multiple genetic disorders
and cellular abnormalities. Globally, cancer is the most common health concern disease that …
and cellular abnormalities. Globally, cancer is the most common health concern disease that …
Nanocarrier-based systems for targeted and site specific therapeutic delivery
Systemic drug delivery methods such as oral or parenteral administration of free drugs
possess relatively low treatment efficiency and marked adverse side effects. The use of …
possess relatively low treatment efficiency and marked adverse side effects. The use of …
[HTML][HTML] Nanotechnology approaches for inhalation treatment of lung diseases
A Kuzmov, T Minko - Journal of controlled release, 2015 - Elsevier
Local administration of therapeutics by inhalation for treatment of lung diseases has the
ability to deliver drugs, nucleic acids and peptides specifically to the site of their action and …
ability to deliver drugs, nucleic acids and peptides specifically to the site of their action and …
Multifunctional and stimuli-responsive nanocarriers for targeted therapeutic delivery
J Majumder, T Minko - Expert opinion on drug delivery, 2021 - Taylor & Francis
Introduction Nanocarrier-based delivery systems offer multiple benefits to overcome
limitations of the traditional drug dosage forms, such as protection of the drug, enhanced …
limitations of the traditional drug dosage forms, such as protection of the drug, enhanced …
Drug delivery and nanoparticles: applications and hazards
WH De Jong, PJA Borm - International journal of nanomedicine, 2008 - Taylor & Francis
The use of nanotechnology in medicine and more specifically drug delivery is set to spread
rapidly. Currently many substances are under investigation for drug delivery and more …
rapidly. Currently many substances are under investigation for drug delivery and more …
[HTML][HTML] Strategy to enhance lung cancer treatment by five essential elements: inhalation delivery, nanotechnology, tumor-receptor targeting, chemo-and gene therapy
OB Garbuzenko, A Kuzmov, O Taratula, SR Pine… - Theranostics, 2019 - ncbi.nlm.nih.gov
Abstract Non-Small Cell Lung Carcinoma (NSCLC), is the most common type of lung cancer
(more than 80% of all cases). Small molecule Tyrosine Kinase (TK) Inhibitors acting on the …
(more than 80% of all cases). Small molecule Tyrosine Kinase (TK) Inhibitors acting on the …
[HTML][HTML] Rational design of liposomal drug delivery systems, a review: Combined experimental and computational studies of lipid membranes, liposomes and their …
Combined experimental and computational studies of lipid membranes and liposomes, with
the aim to attain mechanistic understanding, result in a synergy that makes possible the …
the aim to attain mechanistic understanding, result in a synergy that makes possible the …
Liposomal drug formulations in cancer therapy: 15 years along the road
M Slingerland, HJ Guchelaar, H Gelderblom - Drug discovery today, 2012 - Elsevier
Liposomes as pharmaceutical drug carriers were developed to increase antitumour efficacy
and decrease drug toxicity. Doxorubicin HCl liposomal injection was the first liposomal …
and decrease drug toxicity. Doxorubicin HCl liposomal injection was the first liposomal …